Acorah Software Products - Accounts Production 16.7.461 false true 31 August 2024 1 September 2023 false true No description of principal activity 1 September 2024 31 August 2025 31 August 2025 14321413 Sanah Ajmal iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14321413 2024-08-31 14321413 2025-08-31 14321413 2024-09-01 2025-08-31 14321413 frs-core:CurrentFinancialInstruments 2025-08-31 14321413 frs-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 14321413 frs-bus:FilletedAccounts 2024-09-01 2025-08-31 14321413 frs-bus:Micro-entities 2024-09-01 2025-08-31 14321413 frs-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 14321413 frs-bus:Director1 2024-09-01 2025-08-31 14321413 frs-bus:Director1 2024-08-31 14321413 frs-bus:Director1 2025-08-31 14321413 2023-08-31 14321413 2024-08-31 14321413 2023-09-01 2024-08-31 14321413 frs-core:CurrentFinancialInstruments 2024-08-31
Registered number: 14321413
SAR Pharm Limited
Unaudited Financial Statements
For The Year Ended 31 August 2025
SAR Pharm Limited
Statement of Financial Position
As At 31 August 2025
Statement of Financial Position
Registered number: 14321413

| 2025 | 2024
--- | --- | ---
|  | £ | £
Fixed assets |  | 1,176 | 884
Current assets |  | 13,471 | 23,687
Creditors: Amounts Falling Due Within One Year |  | (7,878 ) | (18,525 )
NET CURRENT ASSETS |  | 5,593 | 5,162
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 6,769 | 6,046
Accruals and deferred income |  | (420 ) | (420 )
NET ASSETS |  | 6,349 | 5,626
CAPITAL AND RESERVES |  | 6,349 | 5,626

## Notes

1. General Information
SAR Pharm Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14321413 . The registered office is 6 Waidshouse Close, Nelson, BB9 0SW.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:

| As at 1 September 2024 | Amounts advanced | Amounts repaid | Amounts written off | As at 31 August 2025
--- | --- | --- | --- | --- | ---
| £ | £ | £ | £ | £
Sanah Ajmal | 9,053 | - | 537 | - | 8,516

The above loan is unsecured, interest free and repayable on demand.
Page 0
Page 1
SAR Pharm Limited
Statement of Financial Position (continued)
As At 31 August 2025
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Sanah Ajmal Director
07/01/2026